Izrael - hebrejština - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 9.375 mg; milbemycin oxime 1.875 mg

Izrael - hebrejština - Ministry of Health

eli lilly israel ltd, israel - fluoxetine as hydrochloride - קפסולות - fluoxetine as hydrochloride 20 mg - fluoxetine

Izrael - hebrejština - Ministry of Health

bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.23 mg - ozanimod

Izrael - hebrejština - Ministry of Health

bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.46 mg - ozanimod

Izrael - hebrejština - Ministry of Health

bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.92 mg - ozanimod

Izrael - hebrejština - Ministry of Health

rafa laboratories ltd - omeprazole - קפסולות - omeprazole 20 mg - omeprazole - omeprazole - relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.

Izrael - hebrejština - Ministry of Health

rafa laboratories ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (gerd) or duodenal ulcer. prevention of relapse in patients with gerd or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Izrael - hebrejština - Ministry of Health

rafa laboratories ltd - lansoprazole - קפסולות - lansoprazole 15 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (gerd) or duodenal ulcer. prevention of relapse in patients with gerd or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Izrael - hebrejština - Ministry of Health

rafa laboratories ltd - mesalazine - caplets - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

Izrael - hebrejština - Ministry of Health

rafa laboratories ltd - mesalazine - פתילות - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.